![Guy MacDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Guy MacDonald
Vorsitzender bei
SCYNEXIS, INC.
Vermögen: 12 130 $ am 31.05.2026
Profil
Mr. Guy MacDonald is a Chairman at SCYNEXIS, Inc. Mr. MacDonald was previously employed as an Executive Vice President-Operations by Idenix Pharmaceuticals LLC, a Vice President-Anti Infective & Hospital Products by Merck & Co., Inc., and a Chairman by Spring Bank Pharmaceuticals, Inc. He also served on the board at Tetraphase Pharmaceuticals, Inc. He received his undergraduate degree from the University Of Dundee.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SCYNEXIS, INC. 0.02% | 01.04.2026 | 17’206 ( 0.02% ) | 12 130 $ | 31.05.2026 |
Aktive Positionen von Guy MacDonald
| Unternehmen | Position | Beginn |
|---|---|---|
| SCYNEXIS, INC. | Vorsitzender | 04.06.2015 |
Ehemalige bekannte Positionen von Guy MacDonald
| Unternehmen | Position | Ende |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 01.08.2019 |
| SPRING BANK PHARMACEUTICALS, INC. | Vorsitzender | 17.08.2015 |
| IDENIX PHARMACEUTICALS INC | Geschäftsführer | 01.01.2008 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Guy MacDonald
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
